Integrative Cancer Care was created by
Professor Ben Pfeifer, M.D., Ph.D.

More about Professor Pfeifer
Professor Ben Pfeifer, M.D., Ph.D. is a passionate medical doctor and scientist for more than 47 years. He received his medical education and specialty training in Germany, the USA, and Switzerland. His specialties and main interests are intensive care medicine, immunology, oncology, and stem cell research. For the last 25 years, he has researched and practiced in the field of complementary cancer care consulting patients worldwide. For his achievements, he was honored with the Humboldt-Prize in Germany and the Immunology-Research Prize in the USA. He has published over 70 articles in peer-reviewed medical journals, several book chapters for medical textbooks, and the first textbook of “Integrative Oncology”. Professor Ben Pfeifer is the Director for Research & Development, at Aeskulap-International in Switzerland and the founder of Integrative Cancer Care.

Anaesthesiology & Intensive Care Medicine, Cancer Immunology, Integrative Oncology

  • Medical Studies and Specialty Training at Humboldt-University, Berlin
  • Consultant Physician at Department of Anesthesiology and Intensive Care at Humboldt-University Medical Centre, Berlin
  • Senior Consultant Physician at the Institute of Physiology, Pathophysiology and Biochemistry at Humboldt-University, Berlin
  • Senior Consultant Physician in the Department of Anesthesiology / Intensive Care at Philipps University, Marburg
  • Medical Director at the Cancer and Pain Treatment Centre, Bad Mergentheim
  • Visiting Professor and Fellow at University of South Florida, Tampa
  • Medical Director of Immune Therapy Clinic, Playas de Tijuana
  • Visiting Professor at University of California, San Diego
  • Second Specialty Training at University of Kentucky, Lexington
  • Assistant Professor, Director for Clinical Research and Attending Physician, Department of Anesthesiology, University Medical Centre, University of Kentucky, Lexington
  • Senior Consulting Physician at the Department of Oncology of Aeskulap Hospital, Brunnen
  • Director for Clinical Research at Aeskulap Hospital, Brunnen
  • Director for Research and Development at Aeskulap-Asia BHD. SDN., Penang
  • Director of Research and Development at Aeskulap-International, Lucerne
  • Director of Research and Development at Aeskulap-International, Lucerne
  • Director for Research and Development at ZOMOROD IDEH Middle East, Ras Al Khaimah
  • Director for Research and Development at Aeskulap-Asia, BHD. SDN., Kuala Lumpur
  • Research Advisor at La Jung Clinic, Kuala Lumpur
  • 76 publications in peer reviewed medical journals
  • 1 book (first text book on “Integrative Oncology”); several book chapters in other medical textbooks
  • 56 presented papers at national and international medical conferences
  • Invited lecturer at the Academy of Sciences in Germany, Russia, USA and Poland
  • Humboldt-Prize
  • Immunological Research Prize
Professor Ben Pfeifer, M.D., Ph.D. is a passionate medical doctor and scientist for 47 years. He received his medical education and specialty training in Germany, the USA, and Switzerland. His specialties and main interests are intensive care medicine, immunology, oncology, and stem cell research. For more than 25 years, he researches and practices in the field of complementary cancer care consulting patients worldwide. For his achievements, Pfeifer was honoured with the Humboldt-Prize in Germany and the Immunology-Research Prize in the USA. He has published over 70 articles in peer-reviewed medical journals, several book chapters for medical textbooks, and the first textbook of “Integrative Oncology”. Professor Ben Pfeifer is the Director for Research & Development, at Aeskulap-International in Switzerland and the founder of Integrative Cancer Care.

Anaesthesiology & Intensive Care Medicine, Cancer Immunology, Integrative Oncology

  • Medical Studies and Specialty Training at Humboldt-University, Berlin
  • Consultant Physician at Department of Anesthesiology and Intensive Care at Humboldt-University Medical Centre, Berlin
  • Senior Consultant Physician at the Institute of Physiology, Pathophysiology and Biochemistry at Humboldt-University, Berlin
  • Senior Consultant Physician in the Department of Anesthesiology / Intensive Care at Philipps University, Marburg
  • Medical Director at the Cancer and Pain Treatment Centre, Bad Mergentheim
  • Visiting Professor and Fellow at University of South Florida, Tampa
  • Medical Director of Immune Therapy Clinic, Playas de Tijuana
  • Visiting Professor at University of California, San Diego
  • Second Specialty Training at University of Kentucky, Lexington
  • Assistant Professor, Director for Clinical Research and Attending Physician, Department of Anesthesiology, University Medical Centre, University of Kentucky, Lexington
  • Senior Consulting Physician at the Department of Oncology of Aeskulap Hospital, Brunnen
  • Director for Clinical Research at Aeskulap Hospital, Brunnen
  • Director for Research and Development at Aeskulap-Asia BHD. SDN., Penang
  • Director of Research and Development at Aeskulap-International, Lucerne
  • Director of Research and Development at Aeskulap-International, Lucerne
  • Director for Research and Development at ZOMOROD IDEH Middle East, Ras Al Khaimah
  • Director for Research and Development at Aeskulap-Asia, BHD. SDN., Kuala Lumpur
  • Research Advisor at La Jung Clinic, Kuala Lumpur
  • 76 publications in peer reviewed medical journals
  • 1 book (first text book on “Integrative Oncology”); several book chapters in other medical textbooks
  • 56 presented papers at national and international medical conferences
  • Invited lecturer at the Academy of Sciences in Germany, Russia, USA and Poland
  • Humboldt-Prize
  • Immunological Research Prize
More info about Prof. pfeifer

The Pfeifer-Protocol

The ‘Pfeifer-Protocol’ is a collection of cancer treatment protocols developed and successfully practiced by Professor Ben Pfeifer, M.D., Ph.D. and his team of internationally acclaimed clinicians. These protocols are meant to help cancer patients and their physicians to achieve best possible treatment results, reduce suffering, and improve quality of life as well as life expectancy by combining leading edge conventional treatment methods with effective complementary-oncology measures.

How the name came about…

“Let me start by saying that the name for these protocols did not originate with me but was coined by patients of mine and their doctors. In my personal view, I think the name, ‘Pfeifer Protocol’, is a bit pretentious since we only compiled some of our most effective treatment protocols over the years. I do not claim in any way that these treatment protocols are comprehensive or have general validity. The protocols have been developed empirically, and they are constantly improved with time. Over the past 20 years, more than 15,000 patients have used our treatment recommendations, many with excellent success. Of course, I hope that this number will become far greater, as our protocols have proved effective in clinical practice again and again, often providing long-lasting benefits to patients, even with advanced cancer.

I hope that the ‘Pfeifer Protocol’ reaches even more therapists and their cancer patients, so that our positive experience with these complementary therapy protocols can be multiplied.”

More about The Pfeifer-Protocol
Prof. Ben Pfeifer

Our International Tumor Board Experts

At age of seventy-two, I have consulted and treated cancer patients from all over the world for more than 30 years. In my “pandemic exile” at our Asian Office, I had this idea of creating an Integrative Cancer Care platform, where patients and their caregivers could get advice regarding diagnostic and treatment, as well as a second opinion service from an international team of medical experts.

I reached out to colleagues and friends in my network – all specialists in their respective medical fields – asking them, whether they would support my idea of an international tumor board for this platform. I was surprised and am very grateful that all agreed to be part of this project providing their professional expertise to cancer patients in need.

The members of our international tumor board are renowned medical doctors, naturopathic doctors, scientists, and experienced clinical practitioners from Switzerland (8), Germany (4), the USA (3), Japan (2), England (1), the UAE (1) and Australia (1) with a vast knowledge base and experience. This team of experts is covering the medical fields of oncological surgery, urology, medical oncology, interventional radiology, radiation therapy, cancer immunology, cancer genetics, stem cell transplantation, internal medicine, cardiology, anesthesiology and interventional pain management, naturopathic oncology, integrative medicine, functional nutrition, herbal medicine, oncological nursing.

Depending on an individual cancer patient’s needs, specific members of our international, multi-disciplinary tumor board will be involved to formulate the best possible cancer care plan, provide second opinion services, and carry-out follow-up consultations for disease monitoring as well as for further diagnostic and treatment. Direct referral to any of these medical specialists is possible.

Hiroyuki Abe
Hiroyuki Abe, M.D., Ph.D., FACC, FACCP
Specialist in Immunology and Oncology
President and Chairman of Tokyo Cancer Clinic
Founder and CEO of Hakushin Koseikai Medical Foundation
Tokyo, Japan
Minako Abe
Minako Abe, M.D., DipABLM

Specialist in Emergency Medicine and Lifestyle Medicine (USA board certifications)
Vice President Tokyo Cancer Clinic and Hakushin Koseikai Medical Foundation

Tokyo, Japan
Rainer Arendt, M.D.

Specialist in Internal Medicine
Subspecialty Cardiology

Zurich, Switzerland
Ani Balmanoukian
Ani Balmanoukian, M.D.

Specialist in Medical Oncology and Hematology
Director of Thoracic Oncology

Los Angeles, CA, USA
Saskia Biskup
Saskia Biskup, M.D., Ph.D.

Specialist in Human Genetics
Director of CeGaT GmbH

Tuebingen, Germany
Christoph Ganss
Christoph Ganss, M.D.

Specialist in General Surgery and General Medicine
Stem Cell Specialist
Director, Founder and CEO of TICEBA GmbH

Heidelberg, Germany
Anwar Giryes
Anwar Giryes, M.D.
Specialist in Internal Medicine
and Complementary Oncology
Kilchberg, Switzerland
dr-Dani-Gordon
Dani Gordon, M.D., CCFP, ABOIM, ABIHM

Specialist in Integrative Medicine (USA Board Certified)
Co-founder of the UK Medical Cannabis Clinicians’s Society (MCCS)

London, United Kingdom
Matthias Guckenberger
Matthias Guckenberger, M.D.

Specialist in Radiation Oncology
Professor and Chairman
Department of Radiation Oncology

Zurich, Switzerland
Rupert Handgretinger
Rupert Handgretinger, M.D., Ph.D.

Specialist in Paediatrics, Oncology and Hematology
Professor at Abu Dhabi Stem Cells Center

Abu Dhabi, UAE
HubertJohn
Hubert John, M.D.

Specialist in Urology
Professor and Director of Department of Urology
EBU Certified Training Centre
Director of the Urological Tumor Center

Winterthur, Switzerland
Abie Mendelsohn
Abie Avraham Mendelsohn, M.D., F.A.C.S.

Specialist in Head and Neck Surgery
Associate Professor of Surgery

Los Angeles, CA, USA
Kiran Nagra
Kiran Nagra
Naturopathic Practitioner
Functional Nutrition and Herbal Medicine
Bachelor of Laws (Hons), Adv Dip Nat.
Perth, Australia
Hans Peter Ogal
Hans Peter Ogal, M.D.
Specialist in Anesthesiology, Interventional Pain Treatment, and Acupuncture

Clinic for Complementary Medicine,
Paramed AG

Baar, Switzerland
Patricia Peat
Patricia Peat

Oncology Nurse
Founder of Cancer Options
Founder of The Peat Institute

London, United Kingdom
Saskia von Sanden
Saskia von Sanden, M.D.
General Practitioner
Naturopathic Medicine, Homoeopathy and Acupuncture
Baden-Baden, Germany
dr-Jan-Schmidt

Jan Schmidt, M.D., Ph.D.

Specialist in Visceral Surgery
and Oncological Surgery
Zurich, Switzerland
Thomas Vogl
Thomas J. Vogl, M.D.
Specialist in Radiology
Professor and Chairman Department of Diagnostic and Interventional Radiology
Frankfurt, Germany
Marcus Schuermann, M.D.
Marcus Schuermann, M.D.
Specialist in Internal Medicine, Hematology and Oncology
Professor at the Oncology and Hematology Center in Zug
Zug, Switzerland
Nasha Winters
Nasha Winters, N.D., FABNO
Specialist in Naturopathic Medicine
Fellow of the American Board of Naturopathic Oncology (FABNO)
Durango, CO, USA
Jan Brügger, M.D.
Jan Brügger, M.D.

Specialist in Internal Medicine
and Nephrology

Horgen, Switzerland
SCHEDULE A CONSULTATION